BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Akiho H, Yokoyama A, Abe S, Nakazono Y, Murakami M, Otsuka Y, Fukawa K, Esaki M, Niina Y, Ogino H. Promising biological therapies for ulcerative colitis: A review of the literature. World J Gastrointest Pathophysiol 2015; 6(4): 219-227 [PMID: 26600980 DOI: 10.4291/wjgp.v6.i4.219]
URL: https://www.wjgnet.com/2150-5330/full/v6/i4/219.htm
Number Citing Articles
1
Qin Zhu, Peifen Zheng, Jianying Zhou, Xinyu Chen, Yuliang Feng, Weifeng Wang, Feng Zhou, Qiaona He. Andrographolide affects Th1/Th2/Th17 responses of peripheral blood mononuclear cells from ulcerative colitis patientsMolecular Medicine Reports 2018;  doi: 10.3892/mmr.2018.8992
2
Domenico Corica, Claudio Romano. Biological Therapy in Pediatric Inflammatory Bowel DiseaseJournal of Clinical Gastroenterology 2017; 51(2): 100 doi: 10.1097/MCG.0000000000000696
3
HaiJing Zhang, GuangMing Song, ZhiHui Zhang, HuaChen Song, XiaoNan Tang, AnJun Deng, WenJie Wang, LianQiu Wu, HaiLin Qin. Colitis Is Effectively Ameliorated by (±)-8-Acetonyl-dihydrocoptisine via the XBP1-NF-κB PathwayFrontiers in Pharmacology 2017; 8 doi: 10.3389/fphar.2017.00619
4
Marisa Iborra, Belén Beltrán, Nuria Maroto, Pablo Navarro-Cortés, Maia Boscá-Watts, Isabel Ferrer-Bradley, Natalia García-Morales, Esteban Sáez-González, Joaquín Hinojosa, Miguel Mínguez, Pilar Nos. Vedolizumab, an option in patients with inflammatory bowel disease intolerant to thiopurines and refractory to biological agentsGastroenterología y Hepatología (English Edition) 2018; 41(9): 535 doi: 10.1016/j.gastre.2018.11.007
5
Tomoko Sairenji, Kimberly L. Collins, David V. Evans. An Update on Inflammatory Bowel DiseasePrimary Care: Clinics in Office Practice 2017; 44(4): 673 doi: 10.1016/j.pop.2017.07.010
6
Marisa Iborra, Belén Beltrán, Nuria Maroto, Pablo Navarro-Cortés, Maia Boscá-Watts, Isabel Ferrer-Bradley, Natalia García-Morales, Esteban Sáez-González, Joaquín Hinojosa, Miguel Mínguez, Pilar Nos. Vedolizumab, una opción en pacientes con enfermedad inflamatoria intestinal intolerantes a tiopurinas y refractarios a biológicosGastroenterología y Hepatología 2018; 41(9): 535 doi: 10.1016/j.gastrohep.2018.06.001
7
Keiichi Tominaga, Mimari Kanazawa, Takanao Tanaka, Shunsuke Kojimahara, Takeshi Sugaya, Shoko Watanabe, Akira Yamamiya, Yuichi Majima, Makoto Iijima, Kenichi Goda, Atsushi Irisawa. A Case of Lung Abscess Caused by Double Immunosuppressive Therapy to Treat Ulcerative ColitisMedicina 2020; 56(11): 595 doi: 10.3390/medicina56110595
8
Renren Bai, Xiaokang Jie, Chuansheng Yao, Yuanyuan Xie. Discovery of small-molecule candidates against inflammatory bowel diseaseEuropean Journal of Medicinal Chemistry 2020; 185: 111805 doi: 10.1016/j.ejmech.2019.111805
9
Chhabi Lal Chaudhary, Prakash Chaudhary, Sadan Dahal, Dawon Bae, Tae-gyu Nam, Jung-Ae Kim, Byeong-Seon Jeong. Inhibition of colitis by ring-modified analogues of 6-acetamido-2,4,5-trimethylpyridin-3-olBioorganic Chemistry 2020; 103: 104130 doi: 10.1016/j.bioorg.2020.104130
10
Nitin Sharma, Anjana Sharma, Aseem Bhatnagar, Dhruv Nishad, Ritu Karwasra, Kushagra Khanna, Deeksha Sharma, Neeraj Kumar, Gaurav Kumar Jain. Novel gum acacia based macroparticles for colon delivery of Mesalazine: Development and gammascintigraphy studyJournal of Drug Delivery Science and Technology 2019; 54: 101224 doi: 10.1016/j.jddst.2019.101224
11
Xian-Qun Chu, Jing Wang, Guang-Xiang Chen, Guan-Qi Zhang, De-Yong Zhang, Yong-Yan Cai. Overexpression of microRNA-495 improves the intestinal mucosal barrier function by targeting STAT3 via inhibition of the JAK/STAT3 signaling pathway in a mouse model of ulcerative colitisPathology - Research and Practice 2018; 214(1): 151 doi: 10.1016/j.prp.2017.10.003
12
Sa-Rang Oh, Seon Ok, Tae-Sung Jung, Sang-Ok Jeon, Ji-Min Park, Ji-wook Jung, Deok-Seon Ryu. Protective effect of decursin and decursinol angelate-rich Angelica gigas Nakai extract on dextran sulfate sodium-induced murine ulcerative colitisAsian Pacific Journal of Tropical Medicine 2017; 10(9): 864 doi: 10.1016/j.apjtm.2017.08.017
13
Philip Minar, Dana MH. Dykes, Ana Catalina Arce-Clachar, Shehzad A. Saeed. Pediatric Inflammatory Bowel Disease2017; : 389 doi: 10.1007/978-3-319-49215-5_32
14
Yunliang Wang, Lijuan Liu, Yi Guo, Tangyou Mao, Rui Shi, Junxiang Li. Effects of indigo naturalis on colonic mucosal injuries and inflammation in rats with dextran sodium sulphate-induced ulcerative colitisExperimental and Therapeutic Medicine 2017; 14(2): 1327 doi: 10.3892/etm.2017.4701
15
Tzu-Chen Lo, Yu-Yen Chen, Hsin-Hua Chen. Risk of inflammatory bowel disease in uveitis patients: a population-based cohort studyEye 2021;  doi: 10.1038/s41433-021-01645-4
16
Titilayo Omolara Johnson, Kenneth Daniel Odoh, Charles Obiora Nwonuma, Augustina Oduje Akinsanmi, Abayomi Emmanuel Adegboyega. Biochemical evaluation and molecular docking assessment of the anti-inflammatory potential of Phyllanthus nivosus leaf against ulcerative colitisHeliyon 2020; 6(5): e03893 doi: 10.1016/j.heliyon.2020.e03893
17
Areeg Bala, Mahmoud Barbarawi, Shima Sidahmed, Ashok Kumar Kanugula, Ghassan Bachuwa. A Cause-Effect Relationship of Infliximab and Pulmonary Embolism: A Case ReportCureus 2020;  doi: 10.7759/cureus.9615
18
Akram Sarabi Asiabar, Hamid Asadzade Aghdaei, Azar Sabokbar, Mohammad Reza Zali, Mohammad Mehdi Feizabadi. Prevalence of Adherent-Invasive Escherichia coli with fimH Gene Isolated from Iranian Patients with Ulcerative ColitisJundishapur Journal of Microbiology 2017; 10(7) doi: 10.5812/jjm.13858
19
Victoria Hall, Douglas Johnson, Joseph Torresi. Travel and biologic therapy: travel-related infection risk, vaccine response and recommendationsJournal of Travel Medicine 2018; 25(1) doi: 10.1093/jtm/tay018
20
Leon D. Averbukh, George Y. Wu. Role of Biologics in the Development of Autoimmune Hepatitis: A ReviewJournal of Clinical and Translational Hepatology 2018; 6(4): 1 doi: 10.14218/JCTH.2018.00039
21
Yan-Meng Lu, Jiao-Jiao Xie, Cong-Gao Peng, Bao-Hong Wang, Kai-Cen Wang, Lan-Juan Li. Enhancing Clinical Efficacy through the Gut Microbiota: A New Field of Traditional Chinese MedicineEngineering 2019; 5(1): 40 doi: 10.1016/j.eng.2018.11.013
22
Shubhasree Banerjee, Ann Biehl, Massimo Gadina, Sarfaraz Hasni, Daniella M. Schwartz. JAK–STAT Signaling as a Target for Inflammatory and Autoimmune Diseases: Current and Future ProspectsDrugs 2017; 77(5): 521 doi: 10.1007/s40265-017-0701-9
23
Yumeng Shen, Junfeng Zou, Mengjun Chen, Zhimiao Zhang, Chen Liu, Shu Jiang, Dawei Qian, Jin-Ao Duan. Protective effects of Lizhong decoction on ulcerative colitis in mice by suppressing inflammation and ameliorating gut barrierJournal of Ethnopharmacology 2020; 259: 112919 doi: 10.1016/j.jep.2020.112919